Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2007 Jun;1(1):14-8.
doi: 10.1016/j.molonc.2007.01.002. Epub 2007 Mar 14.

Europe combating cancer: the European Union's commitment to cancer research in the 6th Framework Programme

Stefan Jungbluth  1 , Olaf Kelm, Jan-Willem van de Loo, Elengo Manoussaki, Maria Vidal, Manuel Hallen, Octavi Quintana Trias
Affiliations

Europe combating cancer: the European Union's commitment to cancer research in the 6th Framework Programme

Stefan Jungbluth et al. Mol Oncol. 2007 Jun.

Abstract

As one of the major health issues in Europe, cancer was a research priority in the 6th Framework Programme (2002-2006). About 485 million euros were devoted to this theme, which allowed funding of 108 multidisciplinary transnational projects. A significant part of them was large-scale initiatives addressing complex issues through a broad combination of competences. All major types of cancer were covered, as well as the three dimensions such as prevention, diagnostic and treatment, with a particular emphasis on translational research aiming at bringing basic knowledge on medical practice. This approach will be continued in the 7th Framework Programme (2007-2013), together with a strengthened effort to improve the coordination of European cancer research, which is fragmented and in which EU action represents only a small part. EU cancer research will also be addressed within the reinforced efforts in the areas of pharmaceutical and technological developments as well as common aetiological mechanisms of diseases that the 7th Framework Programme will undertake.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Spending on cancer research under FP6. (a) Total spending (€485 million) of the European Commission in FP6 (2002–2006) according to the five different areas described in the text (in million Euro). (b) Total spending (in million Euro) according to various subgroups in each of the five areas. The same colour codes apply in (a) and (b).
Figure 2
Figure 2
Relation of different cancers funded in FP6 projects and their incidence in Europe. Numbers of projects funded on particular cancer sites in relation to 5‐year median survival rates and incidence in Europe (Boyle and Ferlay, 2005; Desdouits et al., 2006). Grey circle shows only cancer type currently not covered (testicular cancer) in FP6. Numbers in blue circles indicate the number of projects dealing with a particular cancer type.
Figure 3
Figure 3
FP6 projects on molecular targets. Numbers of projects funded on molecular targets according to the six hallmarks of cancer (Hanahan and Weinberg, 2000). Forty‐six out of the 108 total cancer research‐related projects in FP6 fall in these six categories.
See this image and copyright information in PMC

References

    1. Boyle, P. , Ferlay, J. , 2005. Cancer incidence and mortality in Europe, 2004. Ann. Oncol.. 16, 481–488. - PubMed
    1. Boyle, P. , 2003. European code against cancer and scientific justification: third version. Ann. Oncol.. 14, 973–1005. - PubMed
    1. Desdouits, F., Parnis, S., Berthon, S., Meunier, V., 2006. Oncology pipelines: searching is not finding. Bionest partners, Exane BNP Paribas.
    1. Eckhouse, S. , Sullivan, R. , 2006. A survey of public funding of cancer research in the European Union. PLoS. 3, 994–999. - PMC - PubMed
    1. Hanahan, D. , Weinberg, R.A. , 2000. The hallmarks of cancer. Cell.. 100, 57–70. - PubMed